Clinical Pharmacology Update: Duzallo
February 24th 2018The FDA has approved Duzallo (lesinurad and allopurinol; Ironwood Pharmaceuticals, Inc) for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid (sUA) levels with a medically appropriate daily dose of allopurinol alone.
Read More
The FDA has approved Symplmed's Prestalia (perindopril arginine and amlodipine besylate) tablets for the treatment of hypertension to lower blood pressure in patients who are not adequately controlled with monotherapy or as initial therapy in patients likely to need multiple medications to achieve their blood pressure (BP) goals.1 An estimated 1 in 3 Americans have hypertension, about half of whom have it controlled.
Read More